New drugs for diabetes

Diabetes is a serious problem in many countries. Over time, the high circulating glucose concentration of diabetes leads to various complicating diseases, including heart attack, stroke, blindness, kidney failure, and lower limb amputation, that impose huge healthcare burdens on society. Our group uses mouse model and omics to explore new metabolic hormones for the treatment of diabetes.

The advantages of protein therapeutics have several advantages over small-molecule drugs: (1) the therapeutic actions are highly specific; (2) cause fewer side effects; and (3) usually well tolerated.

With support of GRF and HMRF grants, we have identified several promising targets. We open any kind of collaboration opportunities (including contract research) with biotechnology and pharmaceutical companies in new anti-diabetic drug discovery.

Team Member(s):

Lo Tak Ho

Dr Wong Chi Ming

Mr Duncan CHAN